Clinical investigation of medicinal products in the treatment of Myasthenia Gravis
HumanScientific guidelines
Danish is available via eTranslation, the European Commission's machine translation service.
Translate to Danish | Important information about machine translation
There is currently no guidance on clinical investigation of medicinal products in the treatment of Myasthenia Gravis (MG). Although a few medicinal products have been authorised for the treatment of MG, drug development in this area continues actively and represents a rapidly evolving field. This dynamic landscape justifies the need for an up-to-date and comprehensive regulatory guidance.
Keyword: Myasthenia Gravis, acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), low-density lipoprotein receptor-related protein 4 (LRP4), guideline, confirmatory trials